Publications by authors named "Derek Cruickshank"

Claim this Profile
R
Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II.
Maaike H M Oonk, Brian Slomovitz, Peter J W Baldwin, Helena C van Doorn, Jacobus van der Velden, Derek J Cruickshank

J Clin Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Early Cervical Stromal Invasion FIGO Stage 1A1 When Margins Are Involved With Cervical Intraepithelial Neoplasia.
Rachel C Nicholson, Jeremy Twigg, Alison Roberts, Georgios Angelopoulos, Derek Cruickshank

J Low Genit Tract Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Usha Menon, Alistair J McGuire, Maria Raikou, Andy Ryan, Susan K Davies, Derek Cruickshank

Br J Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practice.
Christina Fotopoulou, Marcia Hall, Derek Cruickshank, Hani Gabra, Raji Ganesan

Eur J Obstet Gynecol Reprod Biol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Derek Cruickshank

Lancet· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.
Usha Menon, Andy Ryan, Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Anne Dawnay, Derek Cruickshank

J Clin Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials.
Matthew Burnell, Aleksandra Gentry-Maharaj, Andy Ryan, Sophia Apostolidou, Mariam Habib, Derek Cruickshank

Trials· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.
Ian Jacobs, Aleksandra Gentry-Maharaj, Matthew Burnell, Ranjit Manchanda, Naveena Singh, Derek Cruickshank

Lancet Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Usha Menon, Aleksandra Gentry-Maharaj, Rachel Hallett, Andy Ryan, Matthew Burnell, Derek Cruickshank

Lancet Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study.
Usha Menon, Aleksandra Gentry-Maharaj, Andy Ryan, Aarti Sharma, Matthew Burnell, Derek Cruickshank

BMJ· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Providing a quality service: direct referral from the cytology laboratory to the colposcopy clinic.
Fiona M Kew, Denise Appleby, Vicki Whittaker, Derek J Cruickshank, Sandra Knott

J Med Screen· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?
Paul M Flynn, Jim Paul, Derek J Cruickshank,

Gynecol Oncol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis